Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study
- PMID: 34464489
- PMCID: PMC9293194
- DOI: 10.1111/1471-0528.16894
Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study
Abstract
Objective: To evaluate whether locally applied vaginal estrogen affects prolapse-associated complaints compared with placebo treatment in postmenopausal women prior to surgical prolapse repair.
Design: Randomised, double-masked, placebo-controlled, multicentre study.
Setting: Urogynaecology unit at the Medical University of Vienna and University Hospital of Tulln.
Population: Postmenopausal women with symptomatic pelvic organ prolapse and planned surgical prolapse repair.
Methods: Women were randomly assigned local estrogen cream or placebo cream 6 weeks preoperatively.
Main outcome measures: The primary outcome was differences in subjective prolapse-associated complaints after 6 weeks of treatment prior to surgery, assessed with the comprehensive German pelvic floor questionnaire. Secondary outcomes included differences in other pelvic floor-associated complaints (bladder, bowel or sexual function).
Results: Out of 120 women randomised, 103 (86%) remained for the final analysis. After 6 weeks of treatment the prolapse domain score did not differ between the estrogen and the placebo groups (4.4 ± 0.19 versus 4.6 ± 0.19; mean difference, -0.21; 95% CI -0.74 to 0.33; P = 0.445). Multivariate analysis, including only women receiving the intervention, showed that none of the confounding factors modified the response to estradiol.
Conclusions: These results demonstrate that preoperative locally applied estrogen does not ameliorate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse.
Tweetable abstract: Preoperative local estrogen does not ameliorate prolapse-associated symptoms in postmenopausal women with pelvic organ prolapse.
Keywords: Local estrogen therapy; pelvic organ prolapse; postmenopausal women.
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Figures
Comment in
-
Vaginal estrogen is unlikely to improve advanced prolapse symptoms.BJOG. 2021 Dec;128(13):2208. doi: 10.1111/1471-0528.16900. Epub 2021 Sep 20. BJOG. 2021. PMID: 34473892 No abstract available.
References
-
- Basu M, Wise B, Duckett J. A qualitative study of women's preferences for treatment of pelvic floor disorders. BJOG 2011;118:338–44. - PubMed
-
- Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501–6. - PubMed
-
- Iosif CS, Batra S, Ek A, Astedt B. Estrogen receptors in the human female lower uninary tract. Am J Obstet Gynecol 1981;141:817–20. - PubMed
-
- Robinson D, Cardozo L. Estrogens and the lower urinary tract. Neurourol Urodyn 2011;30:754–7. - PubMed
-
- Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W. Effective treatment of vaginal atrophy with an ultra‐low‐dose estradiol vaginal tablet. Obstet Gynecol 2008;112:1053–60. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
